nodes	percent_of_prediction	percent_of_DWPC	metapath
Promethazine—CYP2D6—Hydroxyurea—head and neck cancer	0.126	0.407	CbGbCtD
Promethazine—CYP2C9—Fluorouracil—head and neck cancer	0.0526	0.17	CbGbCtD
Promethazine—ABCB1—Vinblastine—head and neck cancer	0.0473	0.153	CbGbCtD
Promethazine—CYP2D6—Vinblastine—head and neck cancer	0.0445	0.144	CbGbCtD
Promethazine—ABCB1—Docetaxel—head and neck cancer	0.039	0.126	CbGbCtD
Promethazine—CALM1—superior cervical ganglion—head and neck cancer	0.025	0.118	CbGeAlD
Promethazine—Gangrene—Hydroxyurea—head and neck cancer	0.0206	0.107	CcSEcCtD
Promethazine—CALM1—trigeminal nerve—head and neck cancer	0.0141	0.0669	CbGeAlD
Promethazine—HRH1—nose—head and neck cancer	0.0131	0.0622	CbGeAlD
Promethazine—CALM1—cranial nerve—head and neck cancer	0.0101	0.0477	CbGeAlD
Promethazine—HTR2A—trigeminal nerve—head and neck cancer	0.0086	0.0407	CbGeAlD
Promethazine—CALM2—ear—head and neck cancer	0.00823	0.039	CbGeAlD
Promethazine—CALM1—ear—head and neck cancer	0.00819	0.0388	CbGeAlD
Promethazine—HTR2A—cranial nerve—head and neck cancer	0.00613	0.029	CbGeAlD
Promethazine—Sensory loss—Vinblastine—head and neck cancer	0.00569	0.0297	CcSEcCtD
Promethazine—Extravasation—Vinblastine—head and neck cancer	0.00565	0.0295	CcSEcCtD
Promethazine—CHRM3—exocrine gland—head and neck cancer	0.00465	0.022	CbGeAlD
Promethazine—CALM2—exocrine gland—head and neck cancer	0.00455	0.0216	CbGeAlD
Promethazine—CALM1—exocrine gland—head and neck cancer	0.00453	0.0215	CbGeAlD
Promethazine—CALM2—hair follicle—head and neck cancer	0.00434	0.0205	CbGeAlD
Promethazine—Phlebitis—Vinblastine—head and neck cancer	0.00415	0.0217	CcSEcCtD
Promethazine—Necrosis—Fluorouracil—head and neck cancer	0.00412	0.0215	CcSEcCtD
Promethazine—Sensory loss—Fluorouracil—head and neck cancer	0.00373	0.0195	CcSEcCtD
Promethazine—Extravasation—Fluorouracil—head and neck cancer	0.00371	0.0193	CcSEcCtD
Promethazine—Disorientation—Hydroxyurea—head and neck cancer	0.00365	0.019	CcSEcCtD
Promethazine—CHRM5—epithelium—head and neck cancer	0.00362	0.0171	CbGeAlD
Promethazine—CALM2—mouth—head and neck cancer	0.0034	0.0161	CbGeAlD
Promethazine—CALM1—mouth—head and neck cancer	0.00339	0.016	CbGeAlD
Promethazine—Dermatitis contact—Fluorouracil—head and neck cancer	0.0032	0.0167	CcSEcCtD
Promethazine—CALM3—parotid gland—head and neck cancer	0.00302	0.0143	CbGeAlD
Promethazine—Necrosis—Docetaxel—head and neck cancer	0.00298	0.0155	CcSEcCtD
Promethazine—Coma—Fluorouracil—head and neck cancer	0.00296	0.0154	CcSEcCtD
Promethazine—CALM2—neck—head and neck cancer	0.00291	0.0138	CbGeAlD
Promethazine—CALM1—neck—head and neck cancer	0.0029	0.0137	CbGeAlD
Promethazine—CALM3—saliva-secreting gland—head and neck cancer	0.00289	0.0137	CbGeAlD
Promethazine—CHRM4—head—head and neck cancer	0.00287	0.0136	CbGeAlD
Promethazine—Euphoric mood—Fluorouracil—head and neck cancer	0.00278	0.0145	CcSEcCtD
Promethazine—Depression—Vinblastine—head and neck cancer	0.00275	0.0143	CcSEcCtD
Promethazine—Thrombophlebitis—Fluorouracil—head and neck cancer	0.00271	0.0141	CcSEcCtD
Promethazine—CHRM1—parotid gland—head and neck cancer	0.00271	0.0128	CbGeAlD
Promethazine—Extravasation—Docetaxel—head and neck cancer	0.00268	0.014	CcSEcCtD
Promethazine—Photosensitivity—Fluorouracil—head and neck cancer	0.00267	0.0139	CcSEcCtD
Promethazine—Swelling—Fluorouracil—head and neck cancer	0.00266	0.0139	CcSEcCtD
Promethazine—Disorientation—Fluorouracil—head and neck cancer	0.00263	0.0137	CcSEcCtD
Promethazine—CHRM1—saliva-secreting gland—head and neck cancer	0.00259	0.0123	CbGeAlD
Promethazine—Agranulocytosis—Vinblastine—head and neck cancer	0.00257	0.0134	CcSEcCtD
Promethazine—Drowsiness—Hydroxyurea—head and neck cancer	0.00251	0.0131	CcSEcCtD
Promethazine—CALM2—parotid gland—head and neck cancer	0.00237	0.0112	CbGeAlD
Promethazine—Injection site reaction—Docetaxel—head and neck cancer	0.00232	0.0121	CcSEcCtD
Promethazine—CHRM3—saliva-secreting gland—head and neck cancer	0.00232	0.011	CbGeAlD
Promethazine—CALM2—saliva-secreting gland—head and neck cancer	0.00227	0.0108	CbGeAlD
Promethazine—CALM1—saliva-secreting gland—head and neck cancer	0.00226	0.0107	CbGeAlD
Promethazine—Hallucination—Hydroxyurea—head and neck cancer	0.00225	0.0117	CcSEcCtD
Promethazine—CHRM5—head—head and neck cancer	0.00225	0.0106	CbGeAlD
Promethazine—Irritability—Fluorouracil—head and neck cancer	0.00224	0.0117	CcSEcCtD
Promethazine—CALM3—trachea—head and neck cancer	0.00223	0.0106	CbGeAlD
Promethazine—CALM2—connective tissue—head and neck cancer	0.00209	0.00988	CbGeAlD
Promethazine—CALM1—connective tissue—head and neck cancer	0.00208	0.00983	CbGeAlD
Promethazine—CHRM1—trachea—head and neck cancer	0.002	0.00947	CbGeAlD
Promethazine—CALM2—epithelium—head and neck cancer	0.00198	0.00938	CbGeAlD
Promethazine—CALM1—epithelium—head and neck cancer	0.00197	0.00934	CbGeAlD
Promethazine—Phlebitis—Docetaxel—head and neck cancer	0.00197	0.0103	CcSEcCtD
Promethazine—Erythema—Hydroxyurea—head and neck cancer	0.00197	0.0102	CcSEcCtD
Promethazine—Thrombophlebitis—Docetaxel—head and neck cancer	0.00196	0.0102	CcSEcCtD
Promethazine—Leukopenia—Vinblastine—head and neck cancer	0.00193	0.0101	CcSEcCtD
Promethazine—Swelling—Docetaxel—head and neck cancer	0.00192	0.01	CcSEcCtD
Promethazine—Convulsion—Vinblastine—head and neck cancer	0.00187	0.00973	CcSEcCtD
Promethazine—ADRA1A—epithelium—head and neck cancer	0.00186	0.0088	CbGeAlD
Promethazine—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00185	0.00966	CcSEcCtD
Promethazine—HTR2A—neck—head and neck cancer	0.00176	0.00836	CbGeAlD
Promethazine—CALM3—thyroid gland—head and neck cancer	0.00176	0.00835	CbGeAlD
Promethazine—Leukopenia—Hydroxyurea—head and neck cancer	0.00176	0.00917	CcSEcCtD
Promethazine—CALM2—trachea—head and neck cancer	0.00175	0.00829	CbGeAlD
Promethazine—CALM1—trachea—head and neck cancer	0.00174	0.00826	CbGeAlD
Promethazine—Thrombocytopenia—Vinblastine—head and neck cancer	0.00172	0.00898	CcSEcCtD
Promethazine—Convulsion—Hydroxyurea—head and neck cancer	0.0017	0.00888	CcSEcCtD
Promethazine—Agranulocytosis—Fluorouracil—head and neck cancer	0.00169	0.00881	CcSEcCtD
Promethazine—Oedema—Hydroxyurea—head and neck cancer	0.0016	0.00836	CcSEcCtD
Promethazine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.00157	0.00819	CcSEcCtD
Promethazine—CHRM2—head—head and neck cancer	0.00154	0.0073	CbGeAlD
Promethazine—Decreased appetite—Vinblastine—head and neck cancer	0.00153	0.00797	CcSEcCtD
Promethazine—CALM2—lymphoid tissue—head and neck cancer	0.00152	0.00722	CbGeAlD
Promethazine—CALM1—lymphoid tissue—head and neck cancer	0.00152	0.00719	CbGeAlD
Promethazine—HRH1—connective tissue—head and neck cancer	0.00151	0.00717	CbGeAlD
Promethazine—Pain—Vinblastine—head and neck cancer	0.0015	0.00784	CcSEcCtD
Promethazine—Constipation—Vinblastine—head and neck cancer	0.0015	0.00784	CcSEcCtD
Promethazine—Arrhythmia—Fluorouracil—head and neck cancer	0.00145	0.00757	CcSEcCtD
Promethazine—Feeling abnormal—Vinblastine—head and neck cancer	0.00145	0.00755	CcSEcCtD
Promethazine—HRH1—epithelium—head and neck cancer	0.00144	0.00681	CbGeAlD
Promethazine—ADRA1A—lymphoid tissue—head and neck cancer	0.00143	0.00678	CbGeAlD
Promethazine—Somnolence—Hydroxyurea—head and neck cancer	0.00143	0.00743	CcSEcCtD
Promethazine—CHRM3—thyroid gland—head and neck cancer	0.00142	0.0067	CbGeAlD
Promethazine—Erythema—Fluorouracil—head and neck cancer	0.00141	0.00737	CcSEcCtD
Promethazine—Dyspepsia—Hydroxyurea—head and neck cancer	0.00141	0.00736	CcSEcCtD
Promethazine—CHRM1—head—head and neck cancer	0.0014	0.00664	CbGeAlD
Promethazine—Decreased appetite—Hydroxyurea—head and neck cancer	0.00139	0.00727	CcSEcCtD
Promethazine—CALM2—thyroid gland—head and neck cancer	0.00139	0.00656	CbGeAlD
Promethazine—Fatigue—Hydroxyurea—head and neck cancer	0.00138	0.00721	CcSEcCtD
Promethazine—CALM1—thyroid gland—head and neck cancer	0.00138	0.00653	CbGeAlD
Promethazine—Constipation—Hydroxyurea—head and neck cancer	0.00137	0.00715	CcSEcCtD
Promethazine—Pain—Hydroxyurea—head and neck cancer	0.00137	0.00715	CcSEcCtD
Promethazine—Vision blurred—Fluorouracil—head and neck cancer	0.00133	0.00695	CcSEcCtD
Promethazine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.00132	0.00689	CcSEcCtD
Promethazine—Jaundice—Docetaxel—head and neck cancer	0.00127	0.00664	CcSEcCtD
Promethazine—HRH1—trachea—head and neck cancer	0.00127	0.00602	CbGeAlD
Promethazine—Leukopenia—Fluorouracil—head and neck cancer	0.00127	0.0066	CcSEcCtD
Promethazine—HTR2A—connective tissue—head and neck cancer	0.00126	0.00599	CbGeAlD
Promethazine—Asthenia—Vinblastine—head and neck cancer	0.00126	0.00658	CcSEcCtD
Promethazine—CHRM3—head—head and neck cancer	0.00126	0.00595	CbGeAlD
Promethazine—CALM2—head—head and neck cancer	0.00123	0.00582	CbGeAlD
Promethazine—Convulsion—Fluorouracil—head and neck cancer	0.00123	0.00639	CcSEcCtD
Promethazine—CALM1—head—head and neck cancer	0.00122	0.00579	CbGeAlD
Promethazine—Agranulocytosis—Docetaxel—head and neck cancer	0.00122	0.00636	CcSEcCtD
Promethazine—Diarrhoea—Vinblastine—head and neck cancer	0.0012	0.00627	CcSEcCtD
Promethazine—HTR2A—epithelium—head and neck cancer	0.0012	0.00569	CbGeAlD
Promethazine—Confusional state—Fluorouracil—head and neck cancer	0.00116	0.00607	CcSEcCtD
Promethazine—Dizziness—Vinblastine—head and neck cancer	0.00116	0.00606	CcSEcCtD
Promethazine—Oedema—Fluorouracil—head and neck cancer	0.00115	0.00602	CcSEcCtD
Promethazine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.00115	0.00602	CcSEcCtD
Promethazine—ADRA1A—head—head and neck cancer	0.00115	0.00546	CbGeAlD
Promethazine—Asthenia—Hydroxyurea—head and neck cancer	0.00115	0.006	CcSEcCtD
Promethazine—CYP2B6—lymphoid tissue—head and neck cancer	0.00113	0.00537	CbGeAlD
Promethazine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.00113	0.00589	CcSEcCtD
Promethazine—DRD2—head—head and neck cancer	0.00113	0.00535	CbGeAlD
Promethazine—Tachycardia—Fluorouracil—head and neck cancer	0.00113	0.00587	CcSEcCtD
Promethazine—Headache—Vinblastine—head and neck cancer	0.0011	0.00574	CcSEcCtD
Promethazine—Diarrhoea—Hydroxyurea—head and neck cancer	0.0011	0.00572	CcSEcCtD
Promethazine—CALM3—lymph node—head and neck cancer	0.0011	0.00519	CbGeAlD
Promethazine—Hypotension—Fluorouracil—head and neck cancer	0.00108	0.00562	CcSEcCtD
Promethazine—HTR2A—trachea—head and neck cancer	0.00106	0.00503	CbGeAlD
Promethazine—Dizziness—Hydroxyurea—head and neck cancer	0.00106	0.00553	CcSEcCtD
Promethazine—Arrhythmia—Docetaxel—head and neck cancer	0.00105	0.00546	CcSEcCtD
Promethazine—Insomnia—Fluorouracil—head and neck cancer	0.00104	0.00544	CcSEcCtD
Promethazine—Somnolence—Fluorouracil—head and neck cancer	0.00103	0.00535	CcSEcCtD
Promethazine—Erythema—Docetaxel—head and neck cancer	0.00102	0.00532	CcSEcCtD
Promethazine—Dyspepsia—Fluorouracil—head and neck cancer	0.00102	0.0053	CcSEcCtD
Promethazine—Rash—Hydroxyurea—head and neck cancer	0.00101	0.00527	CcSEcCtD
Promethazine—Dermatitis—Hydroxyurea—head and neck cancer	0.00101	0.00527	CcSEcCtD
Promethazine—Headache—Hydroxyurea—head and neck cancer	0.001	0.00524	CcSEcCtD
Promethazine—Decreased appetite—Fluorouracil—head and neck cancer	0.001	0.00523	CcSEcCtD
Promethazine—Pain—Fluorouracil—head and neck cancer	0.000987	0.00515	CcSEcCtD
Promethazine—Muscle spasms—Docetaxel—head and neck cancer	0.000982	0.00512	CcSEcCtD
Promethazine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000951	0.00496	CcSEcCtD
Promethazine—Syncope—Docetaxel—head and neck cancer	0.000916	0.00477	CcSEcCtD
Promethazine—Leukopenia—Docetaxel—head and neck cancer	0.000914	0.00476	CcSEcCtD
Promethazine—CYP2B6—head—head and neck cancer	0.000914	0.00433	CbGeAlD
Promethazine—Palpitations—Docetaxel—head and neck cancer	0.000902	0.0047	CcSEcCtD
Promethazine—Loss of consciousness—Docetaxel—head and neck cancer	0.000897	0.00468	CcSEcCtD
Promethazine—HRH1—head—head and neck cancer	0.000892	0.00423	CbGeAlD
Promethazine—Convulsion—Docetaxel—head and neck cancer	0.000885	0.00461	CcSEcCtD
Promethazine—CALM2—lymph node—head and neck cancer	0.00086	0.00408	CbGeAlD
Promethazine—CALM1—lymph node—head and neck cancer	0.000856	0.00406	CbGeAlD
Promethazine—Dry mouth—Docetaxel—head and neck cancer	0.00085	0.00443	CcSEcCtD
Promethazine—Confusional state—Docetaxel—head and neck cancer	0.00084	0.00438	CcSEcCtD
Promethazine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000833	0.00434	CcSEcCtD
Promethazine—Oedema—Docetaxel—head and neck cancer	0.000833	0.00434	CcSEcCtD
Promethazine—Shock—Docetaxel—head and neck cancer	0.00082	0.00427	CcSEcCtD
Promethazine—Pruritus—Fluorouracil—head and neck cancer	0.000817	0.00426	CcSEcCtD
Promethazine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000816	0.00425	CcSEcCtD
Promethazine—Tachycardia—Docetaxel—head and neck cancer	0.000813	0.00424	CcSEcCtD
Promethazine—Diarrhoea—Fluorouracil—head and neck cancer	0.00079	0.00412	CcSEcCtD
Promethazine—ABCB1—epithelium—head and neck cancer	0.000787	0.00373	CbGeAlD
Promethazine—Hypotension—Docetaxel—head and neck cancer	0.000779	0.00406	CcSEcCtD
Promethazine—Dizziness—Fluorouracil—head and neck cancer	0.000763	0.00398	CcSEcCtD
Promethazine—Insomnia—Docetaxel—head and neck cancer	0.000754	0.00393	CcSEcCtD
Promethazine—HTR2A—head—head and neck cancer	0.000745	0.00353	CbGeAlD
Promethazine—Somnolence—Docetaxel—head and neck cancer	0.000741	0.00386	CcSEcCtD
Promethazine—Dyspepsia—Docetaxel—head and neck cancer	0.000733	0.00382	CcSEcCtD
Promethazine—Rash—Fluorouracil—head and neck cancer	0.000728	0.00379	CcSEcCtD
Promethazine—Dermatitis—Fluorouracil—head and neck cancer	0.000727	0.00379	CcSEcCtD
Promethazine—Decreased appetite—Docetaxel—head and neck cancer	0.000724	0.00378	CcSEcCtD
Promethazine—Headache—Fluorouracil—head and neck cancer	0.000723	0.00377	CcSEcCtD
Promethazine—Fatigue—Docetaxel—head and neck cancer	0.000718	0.00374	CcSEcCtD
Promethazine—Constipation—Docetaxel—head and neck cancer	0.000712	0.00371	CcSEcCtD
Promethazine—Pain—Docetaxel—head and neck cancer	0.000712	0.00371	CcSEcCtD
Promethazine—ABCB1—trachea—head and neck cancer	0.000696	0.0033	CbGeAlD
Promethazine—Feeling abnormal—Docetaxel—head and neck cancer	0.000687	0.00358	CcSEcCtD
Promethazine—CYP2D6—head—head and neck cancer	0.000679	0.00322	CbGeAlD
Promethazine—HRH1—lymph node—head and neck cancer	0.000625	0.00296	CbGeAlD
Promethazine—ABCB1—lymphoid tissue—head and neck cancer	0.000606	0.00287	CbGeAlD
Promethazine—Asthenia—Docetaxel—head and neck cancer	0.000598	0.00312	CcSEcCtD
Promethazine—Pruritus—Docetaxel—head and neck cancer	0.000589	0.00307	CcSEcCtD
Promethazine—Diarrhoea—Docetaxel—head and neck cancer	0.00057	0.00297	CcSEcCtD
Promethazine—Dizziness—Docetaxel—head and neck cancer	0.000551	0.00287	CcSEcCtD
Promethazine—ABCB1—thyroid gland—head and neck cancer	0.00055	0.00261	CbGeAlD
Promethazine—Rash—Docetaxel—head and neck cancer	0.000525	0.00274	CcSEcCtD
Promethazine—Dermatitis—Docetaxel—head and neck cancer	0.000525	0.00274	CcSEcCtD
Promethazine—Headache—Docetaxel—head and neck cancer	0.000522	0.00272	CcSEcCtD
Promethazine—ABCB1—head—head and neck cancer	0.000488	0.00231	CbGeAlD
Promethazine—ABCB1—lymph node—head and neck cancer	0.000342	0.00162	CbGeAlD
Promethazine—CHRM3—Metabolism—PTEN—head and neck cancer	2.96e-05	0.000103	CbGpPWpGaD
Promethazine—CALM3—Disease—PTEN—head and neck cancer	2.96e-05	0.000103	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—PIK3CA—head and neck cancer	2.96e-05	0.000103	CbGpPWpGaD
Promethazine—CALM2—Adaptive Immune System—AKT1—head and neck cancer	2.95e-05	0.000102	CbGpPWpGaD
Promethazine—CALM1—Adaptive Immune System—AKT1—head and neck cancer	2.95e-05	0.000102	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—PIK3CA—head and neck cancer	2.93e-05	0.000102	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTGS2—head and neck cancer	2.92e-05	0.000102	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—PIK3CA—head and neck cancer	2.92e-05	0.000102	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—MAPK3—head and neck cancer	2.9e-05	0.000101	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—MAPK3—head and neck cancer	2.9e-05	0.000101	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—MAPK1—head and neck cancer	2.87e-05	9.97e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—STAT3—head and neck cancer	2.87e-05	9.97e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—EGFR—head and neck cancer	2.87e-05	9.97e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PTEN—head and neck cancer	2.87e-05	9.96e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PTEN—head and neck cancer	2.87e-05	9.96e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—MAPK1—head and neck cancer	2.86e-05	9.92e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—EGFR—head and neck cancer	2.86e-05	9.92e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTGS2—head and neck cancer	2.85e-05	9.88e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—HRAS—head and neck cancer	2.81e-05	9.75e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.78e-05	9.67e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—STAT3—head and neck cancer	2.78e-05	9.64e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—STAT3—head and neck cancer	2.78e-05	9.64e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—MAPK1—head and neck cancer	2.76e-05	9.59e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—MAPK1—head and neck cancer	2.76e-05	9.59e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—EGFR—head and neck cancer	2.76e-05	9.59e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—EGFR—head and neck cancer	2.76e-05	9.59e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	2.76e-05	9.59e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—HRAS—head and neck cancer	2.76e-05	9.57e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTGS2—head and neck cancer	2.75e-05	9.56e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTGS2—head and neck cancer	2.75e-05	9.56e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—HRAS—head and neck cancer	2.75e-05	9.54e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—MAPK3—head and neck cancer	2.74e-05	9.52e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—HRAS—head and neck cancer	2.74e-05	9.51e-05	CbGpPWpGaD
Promethazine—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	2.73e-05	9.48e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—HRAS—head and neck cancer	2.71e-05	9.42e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—HRAS—head and neck cancer	2.7e-05	9.39e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—IL2—head and neck cancer	2.7e-05	9.38e-05	CbGpPWpGaD
Promethazine—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	2.69e-05	9.33e-05	CbGpPWpGaD
Promethazine—HRH1—GPCR downstream signaling—AKT1—head and neck cancer	2.68e-05	9.31e-05	CbGpPWpGaD
Promethazine—CHRM1—GPCR downstream signaling—AKT1—head and neck cancer	2.67e-05	9.28e-05	CbGpPWpGaD
Promethazine—CHRM3—GPCR downstream signaling—AKT1—head and neck cancer	2.66e-05	9.25e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—IL2—head and neck cancer	2.66e-05	9.23e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—MAPK3—head and neck cancer	2.65e-05	9.21e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—MAPK3—head and neck cancer	2.65e-05	9.21e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—IL2—head and neck cancer	2.65e-05	9.21e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—STAT3—head and neck cancer	2.65e-05	9.2e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—IL2—head and neck cancer	2.64e-05	9.18e-05	CbGpPWpGaD
Promethazine—CHRM2—GPCR downstream signaling—AKT1—head and neck cancer	2.64e-05	9.16e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—IL2—head and neck cancer	2.63e-05	9.15e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—CCND1—head and neck cancer	2.63e-05	9.14e-05	CbGpPWpGaD
Promethazine—ADRA1A—GPCR downstream signaling—AKT1—head and neck cancer	2.63e-05	9.13e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—MAPK1—head and neck cancer	2.61e-05	9.06e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—EGFR—head and neck cancer	2.61e-05	9.06e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—IL2—head and neck cancer	2.61e-05	9.06e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—PIK3CA—head and neck cancer	2.6e-05	9.03e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—IL2—head and neck cancer	2.6e-05	9.03e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—CCND1—head and neck cancer	2.59e-05	8.99e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—CCND1—head and neck cancer	2.58e-05	8.98e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—CCND1—head and neck cancer	2.58e-05	8.95e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—CCND1—head and neck cancer	2.57e-05	8.92e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—STAT3—head and neck cancer	2.56e-05	8.9e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—STAT3—head and neck cancer	2.56e-05	8.9e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PTEN—head and neck cancer	2.55e-05	8.86e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—CCND1—head and neck cancer	2.54e-05	8.83e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PTEN—head and neck cancer	2.54e-05	8.82e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—CCND1—head and neck cancer	2.54e-05	8.81e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MAPK3—head and neck cancer	2.53e-05	8.79e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—MAPK1—head and neck cancer	2.52e-05	8.77e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—MAPK1—head and neck cancer	2.52e-05	8.77e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—EGFR—head and neck cancer	2.52e-05	8.76e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—EGFR—head and neck cancer	2.52e-05	8.76e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—TP53—head and neck cancer	2.52e-05	8.74e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PTEN—head and neck cancer	2.5e-05	8.68e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PTEN—head and neck cancer	2.49e-05	8.66e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—PIK3CA—head and neck cancer	2.49e-05	8.65e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PTEN—head and neck cancer	2.49e-05	8.64e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PTEN—head and neck cancer	2.48e-05	8.62e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling by GPCR—AKT1—head and neck cancer	2.48e-05	8.61e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PTEN—head and neck cancer	2.48e-05	8.61e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—PIK3CA—head and neck cancer	2.48e-05	8.61e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PTEN—head and neck cancer	2.45e-05	8.52e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MAPK3—head and neck cancer	2.45e-05	8.51e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MAPK3—head and neck cancer	2.45e-05	8.51e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PTEN—head and neck cancer	2.45e-05	8.5e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	2.44e-05	8.47e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling by GPCR—AKT1—head and neck cancer	2.43e-05	8.45e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling by GPCR—AKT1—head and neck cancer	2.43e-05	8.42e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling by GPCR—AKT1—head and neck cancer	2.42e-05	8.4e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—TP53—head and neck cancer	2.41e-05	8.37e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—MAPK1—head and neck cancer	2.41e-05	8.37e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—EGFR—head and neck cancer	2.41e-05	8.37e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—HRAS—head and neck cancer	2.41e-05	8.36e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PTEN—head and neck cancer	2.4e-05	8.34e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PTEN—head and neck cancer	2.4e-05	8.34e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—PIK3CA—head and neck cancer	2.4e-05	8.33e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—PIK3CA—head and neck cancer	2.4e-05	8.33e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling by GPCR—AKT1—head and neck cancer	2.39e-05	8.32e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling by GPCR—AKT1—head and neck cancer	2.39e-05	8.29e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—MAPK1—head and neck cancer	2.33e-05	8.09e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—MAPK1—head and neck cancer	2.33e-05	8.09e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—EGFR—head and neck cancer	2.33e-05	8.09e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—EGFR—head and neck cancer	2.33e-05	8.09e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—HRAS—head and neck cancer	2.3e-05	8e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—VEGFA—head and neck cancer	2.29e-05	7.97e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—HRAS—head and neck cancer	2.29e-05	7.96e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—STAT3—head and neck cancer	2.27e-05	7.89e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—PIK3CA—head and neck cancer	2.26e-05	7.86e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	2.26e-05	7.84e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—VEGFA—head and neck cancer	2.25e-05	7.82e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—VEGFA—head and neck cancer	2.25e-05	7.8e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—VEGFA—head and neck cancer	2.24e-05	7.77e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—STAT3—head and neck cancer	2.24e-05	7.76e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—STAT3—head and neck cancer	2.23e-05	7.75e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—STAT3—head and neck cancer	2.22e-05	7.72e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—HRAS—head and neck cancer	2.22e-05	7.7e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—HRAS—head and neck cancer	2.22e-05	7.7e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—VEGFA—head and neck cancer	2.22e-05	7.7e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—STAT3—head and neck cancer	2.22e-05	7.7e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—VEGFA—head and neck cancer	2.21e-05	7.68e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—IL2—head and neck cancer	2.21e-05	7.66e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—STAT3—head and neck cancer	2.2e-05	7.62e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—PIK3CA—head and neck cancer	2.19e-05	7.61e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—PIK3CA—head and neck cancer	2.19e-05	7.61e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—STAT3—head and neck cancer	2.19e-05	7.6e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK3—head and neck cancer	2.17e-05	7.54e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTGS2—head and neck cancer	2.16e-05	7.49e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—CCND1—head and neck cancer	2.15e-05	7.47e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	2.14e-05	7.42e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—IL2—head and neck cancer	2.13e-05	7.41e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—IL2—head and neck cancer	2.13e-05	7.41e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK3—head and neck cancer	2.13e-05	7.4e-05	CbGpPWpGaD
Promethazine—CHRM4—Signaling Pathways—AKT1—head and neck cancer	2.13e-05	7.38e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK3—head and neck cancer	2.12e-05	7.38e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK3—head and neck cancer	2.12e-05	7.35e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK3—head and neck cancer	2.1e-05	7.28e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—HRAS—head and neck cancer	2.09e-05	7.28e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK3—head and neck cancer	2.09e-05	7.26e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—PIK3CA—head and neck cancer	2.09e-05	7.26e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—PIK3CA—head and neck cancer	2.09e-05	7.26e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—CCND1—head and neck cancer	2.08e-05	7.22e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—CCND1—head and neck cancer	2.08e-05	7.22e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PTEN—head and neck cancer	2.08e-05	7.21e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—MAPK1—head and neck cancer	2.07e-05	7.17e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—EGFR—head and neck cancer	2.07e-05	7.17e-05	CbGpPWpGaD
Promethazine—CHRM5—Signaling Pathways—AKT1—head and neck cancer	2.04e-05	7.07e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	2.03e-05	7.06e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTGS2—head and neck cancer	2.03e-05	7.06e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—EGFR—head and neck cancer	2.03e-05	7.06e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—MAPK1—head and neck cancer	2.03e-05	7.04e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—EGFR—head and neck cancer	2.03e-05	7.04e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—HRAS—head and neck cancer	2.03e-05	7.04e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—HRAS—head and neck cancer	2.03e-05	7.04e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling by GPCR—AKT1—head and neck cancer	2.02e-05	7.03e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—PIK3CA—head and neck cancer	2.02e-05	7.02e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—PIK3CA—head and neck cancer	2.02e-05	7.02e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—MAPK1—head and neck cancer	2.02e-05	7.02e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—EGFR—head and neck cancer	2.02e-05	7.02e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—MAPK1—head and neck cancer	2.02e-05	7e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTGS2—head and neck cancer	2.01e-05	7e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—EGFR—head and neck cancer	2.01e-05	7e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PTEN—head and neck cancer	2.01e-05	6.97e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PTEN—head and neck cancer	2.01e-05	6.97e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—MAPK1—head and neck cancer	2e-05	6.93e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—EGFR—head and neck cancer	2e-05	6.93e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—MAPK1—head and neck cancer	1.99e-05	6.91e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—EGFR—head and neck cancer	1.99e-05	6.91e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling by GPCR—AKT1—head and neck cancer	1.96e-05	6.8e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling by GPCR—AKT1—head and neck cancer	1.96e-05	6.8e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—HRAS—head and neck cancer	1.93e-05	6.72e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PTEN—head and neck cancer	1.88e-05	6.53e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—VEGFA—head and neck cancer	1.87e-05	6.51e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—HRAS—head and neck cancer	1.87e-05	6.5e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—HRAS—head and neck cancer	1.87e-05	6.5e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—STAT3—head and neck cancer	1.86e-05	6.45e-05	CbGpPWpGaD
Promethazine—CALM3—Immune System—AKT1—head and neck cancer	1.85e-05	6.42e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—VEGFA—head and neck cancer	1.81e-05	6.3e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—VEGFA—head and neck cancer	1.81e-05	6.3e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.8e-05	6.25e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—STAT3—head and neck cancer	1.8e-05	6.23e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—STAT3—head and neck cancer	1.8e-05	6.23e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	1.79e-05	6.22e-05	CbGpPWpGaD
Promethazine—CALM1—Immune System—AKT1—head and neck cancer	1.79e-05	6.21e-05	CbGpPWpGaD
Promethazine—CALM2—Immune System—AKT1—head and neck cancer	1.79e-05	6.21e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK3—head and neck cancer	1.77e-05	6.16e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PTEN—head and neck cancer	1.77e-05	6.16e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	1.76e-05	6.12e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—PIK3CA—head and neck cancer	1.76e-05	6.11e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PTEN—head and neck cancer	1.76e-05	6.1e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—PIK3CA—head and neck cancer	1.75e-05	6.09e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—PIK3CA—head and neck cancer	1.75e-05	6.08e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—PIK3CA—head and neck cancer	1.75e-05	6.07e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—TP53—head and neck cancer	1.73e-05	6.02e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—PIK3CA—head and neck cancer	1.73e-05	6.01e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—PIK3CA—head and neck cancer	1.73e-05	6e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK3—head and neck cancer	1.72e-05	5.96e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK3—head and neck cancer	1.72e-05	5.96e-05	CbGpPWpGaD
Promethazine—CHRM3—Metabolism—AKT1—head and neck cancer	1.71e-05	5.93e-05	CbGpPWpGaD
Promethazine—CALM3—Disease—AKT1—head and neck cancer	1.71e-05	5.93e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—TP53—head and neck cancer	1.71e-05	5.93e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—TP53—head and neck cancer	1.7e-05	5.91e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—TP53—head and neck cancer	1.7e-05	5.89e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—PIK3CA—head and neck cancer	1.69e-05	5.88e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—PIK3CA—head and neck cancer	1.69e-05	5.88e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—TP53—head and neck cancer	1.69e-05	5.87e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—MAPK1—head and neck cancer	1.69e-05	5.86e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—EGFR—head and neck cancer	1.69e-05	5.86e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—TP53—head and neck cancer	1.68e-05	5.82e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—TP53—head and neck cancer	1.67e-05	5.8e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—HRAS—head and neck cancer	1.66e-05	5.76e-05	CbGpPWpGaD
Promethazine—CALM1—Disease—AKT1—head and neck cancer	1.65e-05	5.74e-05	CbGpPWpGaD
Promethazine—CALM2—Disease—AKT1—head and neck cancer	1.65e-05	5.74e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—MAPK1—head and neck cancer	1.63e-05	5.67e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—MAPK1—head and neck cancer	1.63e-05	5.67e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—EGFR—head and neck cancer	1.63e-05	5.67e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—EGFR—head and neck cancer	1.63e-05	5.67e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—HRAS—head and neck cancer	1.63e-05	5.67e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—HRAS—head and neck cancer	1.63e-05	5.65e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—HRAS—head and neck cancer	1.62e-05	5.64e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—HRAS—head and neck cancer	1.62e-05	5.62e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—HRAS—head and neck cancer	1.6e-05	5.56e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—HRAS—head and neck cancer	1.6e-05	5.55e-05	CbGpPWpGaD
Promethazine—CYP2B6—Metabolism—AKT1—head and neck cancer	1.47e-05	5.1e-05	CbGpPWpGaD
Promethazine—DRD2—Signaling Pathways—AKT1—head and neck cancer	1.46e-05	5.08e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—PIK3CA—head and neck cancer	1.46e-05	5.08e-05	CbGpPWpGaD
Promethazine—HTR2A—Signaling Pathways—AKT1—head and neck cancer	1.44e-05	5e-05	CbGpPWpGaD
Promethazine—HRH1—Signaling Pathways—AKT1—head and neck cancer	1.44e-05	4.99e-05	CbGpPWpGaD
Promethazine—CHRM1—Signaling Pathways—AKT1—head and neck cancer	1.43e-05	4.98e-05	CbGpPWpGaD
Promethazine—CALM3—Metabolism—AKT1—head and neck cancer	1.43e-05	4.97e-05	CbGpPWpGaD
Promethazine—CHRM3—Signaling Pathways—AKT1—head and neck cancer	1.43e-05	4.96e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—TP53—head and neck cancer	1.42e-05	4.92e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—PIK3CA—head and neck cancer	1.42e-05	4.92e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—PIK3CA—head and neck cancer	1.42e-05	4.92e-05	CbGpPWpGaD
Promethazine—CHRM2—Signaling Pathways—AKT1—head and neck cancer	1.41e-05	4.91e-05	CbGpPWpGaD
Promethazine—ADRA1A—Signaling Pathways—AKT1—head and neck cancer	1.41e-05	4.9e-05	CbGpPWpGaD
Promethazine—CALM1—Metabolism—AKT1—head and neck cancer	1.38e-05	4.8e-05	CbGpPWpGaD
Promethazine—CALM2—Metabolism—AKT1—head and neck cancer	1.38e-05	4.8e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—TP53—head and neck cancer	1.37e-05	4.76e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—TP53—head and neck cancer	1.37e-05	4.76e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—HRAS—head and neck cancer	1.35e-05	4.7e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—PIK3CA—head and neck cancer	1.33e-05	4.61e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—HRAS—head and neck cancer	1.31e-05	4.55e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—HRAS—head and neck cancer	1.31e-05	4.55e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	1.25e-05	4.34e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—PIK3CA—head and neck cancer	1.24e-05	4.3e-05	CbGpPWpGaD
Promethazine—CALM3—Signaling Pathways—AKT1—head and neck cancer	1.2e-05	4.15e-05	CbGpPWpGaD
Promethazine—CALM2—Signaling Pathways—AKT1—head and neck cancer	1.16e-05	4.02e-05	CbGpPWpGaD
Promethazine—CALM1—Signaling Pathways—AKT1—head and neck cancer	1.16e-05	4.02e-05	CbGpPWpGaD
Promethazine—ABCB1—Metabolism—AKT1—head and neck cancer	1.08e-05	3.76e-05	CbGpPWpGaD
Promethazine—CYP2D6—Metabolism—AKT1—head and neck cancer	1.02e-05	3.55e-05	CbGpPWpGaD
Promethazine—CYP2C9—Metabolism—AKT1—head and neck cancer	1.01e-05	3.52e-05	CbGpPWpGaD
